Skip to main content

LIVE

AHCO

AdaptHealth Corp.

AHCO

NASDAQ·Healthcare·Medical - Devices·Mkt cap $883.0M

$6.49

+1.09%

P/E

-3.86

Mkt Cap

$883.0M

52-Wk Range

$5.21–$13.43

52-Week Range

$5.21 - $13.43

P/E

-3.86

Fwd P/E

-32.05

Beta

1.39

Div Yield

0.00%

Avg Vol

2.2M

Shares Out

135.9M

Mkt Cap

$883.0M

Price action

Price chart

Down 31.1% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

5 reasons

  • Nationwide distribution network and established relationships with healthcare providers, hospitals, and insurance payors
  • Recurring revenue model from chronic disease management with high customer retention rates
  • Diversified product portfolio reducing dependence on single therapeutic category
  • Scale advantages in procurement, logistics, and reimbursement management
  • Regulatory barriers and insurance network relationships creating switching costs

Bear Case

1 risk

  • Average volatility.

Growth

Mild headwinds expected

Emerging player in Medical - Devices

Value

Deep value opportunity - significant discount to Medical Devices peers

Momentum

Falling

-32.8% over 3m

Quality

Thin

Solid business

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 3, 2026

Q3 26 RECAP

AUG 4, 2026

Reported EPS of $0.06 vs $0.17 consensus (-64.5% surprise). Revenue of $740.3M vs $846.8M expected (-12.6%).

EPS miss
Revenue miss

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-64.5%

Revenue trend · last 8Q

-42%

-2%

-1%

+37%

-1%

+41%

+25%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$597.5M

$856.6M

$580.5M

$591.8M

$820.3M

$846.3M

$819.8M

$740.3M

Margins · last 8Q

Gross

14.1%

Operating

-18.6%

Profit

-18.1%

Wall Street consensus

5 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

5

100%

Hold

0%

Sell

0%

Median Price Target

Latest: UBS · Aug 6, 2026

vs Industry

How AHCO stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.